HHS Regulatory Agenda Omits Drug Pricing Actions – Unless OTC Switches Still Count

HHS’ 'statement of regulatory priorities' for 2018 does not even offer lip service to idea of addressing Rx costs. It does, however, suggest plans to move forward with an effort to increase OTC switches – which was an Obama era idea to lower drug costs.